These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 24457606

  • 1. Pharmacodynamic monitoring of nuclear factor of activated T cell-regulated gene expression in liver allograft recipients on immunosuppressive therapy with calcineurin inhibitors in the course of time and correlation with acute rejection episodes--a prospective study.
    Steinebrunner N, Sandig C, Sommerer C, Hinz U, Giese T, Stremmel W, Zahn A.
    Ann Transplant; 2014 Jan 22; 19():32-40. PubMed ID: 24457606
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Pharmacodynamic monitoring by residual NFAT-regulated gene expression in stable pediatric liver transplant recipients.
    Billing H, Breil T, Schmidt J, Tönshoff B, Schmitt CP, Giese T, Engelmann G.
    Pediatr Transplant; 2012 Mar 22; 16(2):187-94. PubMed ID: 22360403
    [Abstract] [Full Text] [Related]

  • 4. The Calcineurin Inhibitor-Sparing (CIS) Trial - individualised calcineurin-inhibitor treatment by immunomonitoring in renal allograft recipients: protocol for a randomised controlled trial.
    Sommerer C, Schaier M, Morath C, Schwenger V, Rauch G, Giese T, Zeier M.
    Trials; 2014 Dec 13; 15():489. PubMed ID: 25494823
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Molecular and structural consequences of early renal allograft injury.
    Baboolal K, Jones GA, Janezic A, Griffiths DR, Jurewicz WA.
    Kidney Int; 2002 Feb 13; 61(2):686-96. PubMed ID: 11849412
    [Abstract] [Full Text] [Related]

  • 8. A randomized, prospective, pharmacoeconomic trial of neoral 2-hour postdose concentration monitoring versus tacrolimus trough concentration monitoring in de novo liver transplant recipients.
    Shenoy S, Hardinger KL, Crippin J, Korenblat K, Lisker-Melman M, Lowell JA, Chapman W.
    Liver Transpl; 2008 Feb 13; 14(2):173-80. PubMed ID: 18236391
    [Abstract] [Full Text] [Related]

  • 9. Monitoring of calcineurin inhibitors by NFAT-regulated gene expression in de novo renal allograft recipients on cyclosporine A.
    Sommerer C, Zeier M, Meuer S, Giese T.
    Clin Nephrol; 2015 Sep 13; 84(3):165-72. PubMed ID: 26226950
    [Abstract] [Full Text] [Related]

  • 10. Pharmacodynamic monitoring by residual gene expression of the nuclear factor of activated T cell-regulated genes in lung transplant recipients and its correlation with tacrolimus blood levels.
    Boada-Pérez M, Ruiz de Miguel V, Erro M, Ussetti P, Aguilar M, Castejón R, Rosado S, Escobar-Fornieles R, Revilla-López E, Bravo C, Sáez-Giménez B, Zapata-Ortega M, Villena-Ortiz Y, Vima-Bofarull J, Monforte V, Gómez-Ollés S.
    Front Immunol; 2024 Sep 13; 15():1382459. PubMed ID: 38799459
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Nuclear factor of activated T cells as potential pharmacodynamic biomarker for the risk of acute and subclinical rejection in de novo liver recipients.
    Millán O, Ruiz P, Fortuna V, Navasa M, Brunet M.
    Liver Int; 2020 Apr 13; 40(4):931-946. PubMed ID: 31883422
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.